“Realizing Personalized Metabolic Profiling “
QuLab Medical is a digital health start-up, focused on revolutionizing diabetes management, early diagnosis, and prevention, by offering a complete metabolic monitoring solution, based on users’ individual needs. At the helm of affairs is CEO Dr. Idan Tamir who is a seasoned healthcare entrepreneur and inventor. With over 20 years of experience in leading medical device and diagnostic startups, Idan has developed and commercialized multiple products. He believes that his early years as an intelligence officer, followed by his academic career, have strongly shaped his journey as a healthcare entrepreneur.
Idan believes that there is considerable room for future innovation and growth for HC technologies, especially in the fusion of multidisciplinary fields, such as microelectronics, sensors, IoT, and AI to name a few. “This will lead to the development of more personalized solutions for ongoing health monitoring and treatment, allowing the general population to prevent a disease, instead of treating it once it has developed and progressed.”
Qulab Medical develops minimally-invasive continuous glucose monitoring (CGM) systems that enable monitoring additional metabolites. Providing access to continuous metabolic data empowers better and more informed health decisions. They offer a user-friendly way of generating actionable insights into the body’s chemistry, to create a personalized metabolic profile. Qulab is currently focusing on diabetes management and prevention. Their platform is a gateway technology relevant to the management and prevention of multiple diseases and conditions.
QuLab Medical is a digital health startup developing a small, minimally-invasive patch that enables access to continuous metabolic data, empowering better and more informed health decisions. QuLab offers a user-friendly way of generating actionable insights into the body’s chemistry, to create a personalized metabolic profile. The company is currently focusing on diabetes management and prevention.
Developed a Continuous Metabolic Monitoring (CMM) system designed to focus on diabetes management and prevention. The company’s system is based on a nanosensor-based minimally-invasive and user-friendly patch for continuously monitoring glucose and additional metabolites in parallel, generating actionable insights into the body’s chemistry to create personalized metabolic profiles, enabling patients to make informed health decisions.
At Qulab Medical, one of our most memorable moments of success was the eureka instance once we realized that a potentiometric-based approach to glucose monitoring could be superior to the currently-used amperometric approach.